Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.4.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2023. Verfasst von Zhen Ji Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Central serous chorioretinopathy (CSCR) is a leading cause of central vision impairment in the working-age population with male predilection. Knowledge about the genetic basis of CSCR and its male predilection remained limited. This study aimed to evaluate the association patterns of multiple gene variants in chronic CSCR (cCSCR) in Chinese patients.
Methods
This case-control genetic association study included 531 patients with cCSCR and 2383 controls from two independent Chinese cohorts. Nine single-nucleotide polymorphisms (SNPs) of six genes, namely CFH, NR3C2, GATA5, VIPR2, TNFRSF10A, and ARMS2, were genotyped in all subjects. The main outcome measures were the association of individual single-nucleotide polymorphism (SNP) with cCSCR, the sex-stratification effects of individual SNP, and joint effects of different SNPs on cCSCR.
Results
Association results in the two cohorts were consistent with low heterogeneities. In the combined analysis, SNPs CFH rs800292 (odds ratio [OR] = 1.25, P = 0.0020), CFH rs1329428 (OR = 1.23, P = 0.0037), and TNFRSF10A rs13278062 (OR = 1.43, P = 0.0014) were significantly associated with cCSCR. In stratification analysis by sex, 3 SNPs in CFH, rs3753394, rs800292, and rs1329428, were associated with cCSCR in male patients, but not in female patients. Joint analysis revealed that subjects homozygous for the risk alleles of CFH rs800292 and TNFRSF10A rs13278062 had over 4-fold of increased risk of cCSCR when compared with subjects homozygous for the non-risk alleles (OR = 4.06, P = 2.30 × 10-5).
Conclusions
This study revealed main and joint effects of SNPs in CFH and TNFRSF10A on cCSCR, and suggested CFH as a potential genetic factor underlying the male predilection of cCSCR. Further replication in other study populations is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
- Hong Kong Eye Hospital, Hospital Authority, Hong Kong, China.
- Joint Shantou International Eye Centre of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
- Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital Eye Centre, Hong Kong, China.
Zitieren
APA
Chen, Z. J., Ng, D. S. C., Cen, L. P., Ng, T. K., Ho, M., Brelen, M. E., Li, T. P., Lu, S. Y., Tam, P. O. S., Young, A. L., Chen, W., Yam, J. C., Chen, H., Tham, C. C., Pang, C. P., & Chen, L. J. (2023). Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.4.19
Vancouver
Chen ZJ, Ng DSC, Cen LP, Ng TK, Ho M, Brelen ME, et al. Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.4.19
BibTeX
@article{Chen2023,
author = {Chen, Zhen Ji and Ng, Danny S C and Cen, Ling-Ping and Ng, Tsz Kin and Ho, Mary and Brelen, Marten E and Li, Tai-Ping and Lu, Shi Yao and Tam, Pancy O S and Young, Alvin L and Chen, Weiqi and Yam, Jason C and Chen, Haoyu and Tham, Clement C and Pang, Chi Pui and Chen, Li Jia},
title = {Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.4.19}
}
EUVIMED